BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 17461703)

  • 1. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.
    Barnett MJ; Milavetz G; Kaboli PJ
    Pharmacotherapy; 2005 Nov; 25(11):1550-9. PubMed ID: 16232018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of spacer device use by patients with asthma and COPD.
    Guss D; Barash IA; Castillo EM
    J Emerg Med; 2008 Nov; 35(4):357-61. PubMed ID: 18757157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA; Schumock GT; Bartle B; Pickard AS
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
    Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
    Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of beta-blockers in patients with COPD.
    Andrus MR; Holloway KP; Clark DB
    Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation.
    Tsai CL; Griswold SK; Clark S; Camargo CA
    J Gen Intern Med; 2007 Jun; 22(6):799-804. PubMed ID: 17410402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and utilization of COPD and asthma among insured adults in the US.
    Blanchette CM; Broder M; Ory C; Chang E; Akazawa M; Dalal AA
    Curr Med Res Opin; 2009 Jun; 25(6):1385-92. PubMed ID: 19419342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders.
    Lang DM; Alpern MB; Visintainer PF; Smith ST
    Arch Intern Med; 1993 Sep; 153(17):2033-40. PubMed ID: 8102844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of frequent emergency department utilization in Southeastern Pennsylvania.
    Pines JM; Buford K
    J Asthma; 2006 Apr; 43(3):219-23. PubMed ID: 16754525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with acute health care use in a national adult asthma management program.
    Ng TP; Lim TK; Abisheganaden J; Eng P; Sin FL
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):784-93. PubMed ID: 17201238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.
    Au DH; Bryson CL; Fan VS; Udris EM; Curtis JR; McDonell MB; Fihn SD
    Am J Med; 2004 Dec; 117(12):925-31. PubMed ID: 15629731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.